Leveraging Real‐World Data for EMA Qualification of a Model‐Based Biomarker Tool to Optimize Type‐1 Diabetes Prevention Studies

The development of therapies to prevent or delay the onset of type 1 diabetes (T1D) remains challenging, and there is a lack of qualified biomarkers to identify individuals at risk of developing T1D or to quantify the time‐varying risk of conversion to a diagnosis of T1D. To address this drug develo...

Descripción completa

Detalles Bibliográficos
Autores principales: Podichetty, Jagdeep T., Lang, Patrick, O’Doherty, Inish M., David, Sarah E., Muse, Rhoda N., Karpen, Stephen R., Song, Laura Sue, Romero, Klaus, Burton, Jackson K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131426/
https://www.ncbi.nlm.nih.gov/pubmed/35276013
http://dx.doi.org/10.1002/cpt.2559

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9131426/
https://www.ncbi.nlm.nih.gov/pubmed/35276013
http://dx.doi.org/10.1002/cpt.2559

Ejemplares similares